These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8165376)

  • 1. Selected complications of allogeneic bone marrow transplantation.
    Wujcik D; Ballard B; Camp-Sorrell D
    Semin Oncol Nurs; 1994 Feb; 10(1):28-41. PubMed ID: 8165376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications.
    Ferrà C; de Sanjosé S; Lastra CF; Martí F; Mariño EL; Sureda A; Brunet S; Gallardo D; Berlanga JJ; García J; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(12):1075-80. PubMed ID: 9466281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation--clinical and immunological considerations.
    Schlitt HJ; Tischler HJ; Ringe B; Raddatz G; Maschek H; Dietrich H; Kuse E; Pichlmayr R; Link H
    Bone Marrow Transplant; 1995 Sep; 16(3):473-8. PubMed ID: 8535323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic veno-occlusive disease--liver toxicity syndrome after bone marrow transplantation.
    Shulman HM; Hinterberger W
    Bone Marrow Transplant; 1992 Sep; 10(3):197-214. PubMed ID: 1422475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant.
    Rapoport AP; Doyle HR; Starzl T; Rowe JM; Doeblin T; DiPersio JF
    Bone Marrow Transplant; 1991 Nov; 8(5):421-4. PubMed ID: 1768978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of severe hepatic veno-occlusive disease after allogeneic bone marrow transplantation by transjugular intrahepatic portosystemic stent-shunt (TIPS).
    Lévy V; Azoulay D; Rio B; Vincent F; Rabbat A; Hunault M; Bazarbachi A; Delmer A; Zittoun R
    Bone Marrow Transplant; 1996 Aug; 18(2):443-45. PubMed ID: 8864460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients.
    Pihusch R; Salat C; Schmidt E; Göhring P; Pihusch M; Hiller E; Holler E; Kolb HJ
    Transplantation; 2002 Nov; 74(9):1303-9. PubMed ID: 12451270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
    Klaesson S; Ringdén O; Ljungman P; Aschan J; Hägglund H; Winiarski J
    Transplantation; 1995 Dec; 60(11):1225-30. PubMed ID: 8525515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia.
    Rozman C; Carreras E; Qian C; Gale RP; Bortin MM; Rowlings PA; Ash RC; Champlin RE; Henslee-Downey PJ; Herzig RH; Hinterberger W; Klein JP; Prentice HG; Reiffers J; Zwaan FE; Horowitz MM
    Bone Marrow Transplant; 1996 Jan; 17(1):75-80. PubMed ID: 8673059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal dysfunction following bone marrow transplantation.
    Kemmner S; Verbeek M; Heemann U
    J Nephrol; 2017 Apr; 30(2):201-209. PubMed ID: 27589851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver.
    Rosen HR; Martin P; Schiller GJ; Territo M; Lewin DN; Shackleton CR; Busuttil RW
    Liver Transpl Surg; 1996 May; 2(3):225-32. PubMed ID: 9346652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-bone marrow transplant patient management.
    Poliquin CM
    Yale J Biol Med; 1990; 63(5):495-502. PubMed ID: 2293508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation.
    El-Sayed MH; El-Haddad A; Fahmy OA; Salama II; Mahmoud HK
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1347-54. PubMed ID: 15618844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
    Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Related donor liver transplant for veno-occlusive disease following T-depleted unrelated donor bone marrow transplantation.
    Bunin N; Leahey A; Dunn S
    Transplantation; 1996 Feb; 61(4):664-6. PubMed ID: 8610401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
    Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A
    Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients.
    McDonald GB; Hinds MS; Fisher LD; Schoch HG; Wolford JL; Banaji M; Hardin BJ; Shulman HM; Clift RA
    Ann Intern Med; 1993 Feb; 118(4):255-67. PubMed ID: 8420443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications.
    Nürnberger W; Michelmann I; Burdach S; Göbel U
    Ann Hematol; 1998 Feb; 76(2):61-5. PubMed ID: 9540759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of veno-occlusive disease with recombinant tissue plasminogen activator in a patient requiring peritoneal dialysis.
    Simpson DR; Browett PJ; Doak PB; Palmer SJ
    Bone Marrow Transplant; 1994 Oct; 14(4):635-6. PubMed ID: 7858540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
    Remberger M; Ringdén O
    Transplantation; 1995 Dec; 60(11):1293-9. PubMed ID: 8525524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.